Eur Rev Med Pharmacol Sci 2015; 19 (12): 2141-2142

A comment about the use of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma

F. Fiorica

Department of Radiation Oncology, University Hospital “S. Anna”, Ferrara, Italy. francesco.fiorica@unife.it

Free PDF Download

To cite this article

F. Fiorica
A comment about the use of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 12
Pages: 2141-2142

Keywords Related articles:

  1. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial
  2. Radiotherapy and hepatocellular carcinoma: update and review of the literature
  3. A pilot study of conformal radiotherapy combined with erlotinib-based multimodality therapy in newly diagnosed metastatic non-small-cell lung cancer
  4. Metabolic responses in non-small cell lung cancer after hypofractionated stereotactic radiotherapy PET and Hypofractionated Radiotherapy
  5. Comment on Diet and pancreatic cancer: many questions with few certains